Today's Business Headlines
The U.S. Food and Drug Administration said it was aware of the study, which was published in the New England Journal of Medicine, comparing Zithromax to Bayer's Cipro and Johnson & Johnson's Levaquin.
Pfizer's ...
PC sales have been tepid for most of the last year. But volumes registered a surprise 1.9 percent growth in the first quarter of this year, according to Gartner.
Windows 8 OS's long-awaited launch this year is widely ...
Showers expected in Minnesota, northern Iowa, northern Nebraska and the Dakotas this weekend, bringing 1/2 to 1-1/2 inches of rain to those areas, said Joel Widenor, meteorologist with Commodity Weather Group.
The rest ...
(Reuters) - Warren Buffett's Berkshire Hathaway Inc is making another bet on the newspaper industry, with a deal to buy the majority of Media General Inc's papers for $142 million in cash.
Berkshire will also loan $400 ...
SINGAPORE (Reuters) - Even as Facebook fever grips investors ahead of the social networking giant's potential $100 billion-plus initial public offering, its breakneck growth in Asia may be slowing as it moves beyond ...
LONDON, May 17 (IFR) - The euro zone crisis was in full swing when Jean-Claude Trichet took the podium in Berlin last October 6 for his final press conference as president of the European Central Bank. Having helped ...
Human Genome said its board determined the $13-a-share bid by the British drugmaker was inadequate and undervalued the company, and it recommended stockholders not tender their shares.
In a statement, Human Genome said ...
SEOUL (Reuters) - Unlike his colleagues at a Korean city office, Choi Chang-young dreads the end of each workday, when he is forced to return to his empty, echoing house.
"I feel a deep sense of loneliness since ...
(Reuters) - Wal-Mart Stores Inc posted a better-than-expected quarterly profit on Thursday as more people shopped its established U.S. discount stores and spent more money.
The world's largest retailer, which was ...
(Reuters) - Two drugs being developed by GlaxoSmithKline Plc - each designed to block different pathways used by cancer cells - have been shown in a small clinical trial to curb melanoma with fewer side effects than ...
